Jeffrey E. Russel

Array ( [id] => 1325023 [patent_doc_number] => 06602852 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-05 [patent_title] => 'Basic peptides and pharmaceutical compositions containing same' [patent_app_type] => B1 [patent_app_number] => 09/763548 [patent_app_country] => US [patent_app_date] => 2001-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 27 [patent_no_of_words] => 14097 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/602/06602852.pdf [firstpage_image] =>[orig_patent_app_number] => 09763548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 784919 [patent_doc_number] => 06989139 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-01-24 [patent_title] => 'Matrix metalloproteinase inhibitors' [patent_app_type] => utility [patent_app_number] => 09/783248 [patent_app_country] => US [patent_app_date] => 2001-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33912 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/989/06989139.pdf [firstpage_image] =>[orig_patent_app_number] => 09783248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1324990 [patent_doc_number] => 06602849 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-05 [patent_title] => 'Cyclic somatostatin analogs' [patent_app_type] => B1 [patent_app_number] => 09/719784 [patent_app_country] => US [patent_app_date] => 2001-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16538 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 564 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/602/06602849.pdf [firstpage_image] =>[orig_patent_app_number] => 09719784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1080922 [patent_doc_number] => 06835807 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-12-28 [patent_title] => 'Drug complex and drug delivery system' [patent_app_type] => B1 [patent_app_number] => 09/674526 [patent_app_country] => US [patent_app_date] => 2001-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14434 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/835/06835807.pdf [firstpage_image] =>[orig_patent_app_number] => 09674526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1307258 [patent_doc_number] => 06617311 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-09 [patent_title] => 'Regulation of tyrosine hydroxylase' [patent_app_type] => B1 [patent_app_number] => 09/719459 [patent_app_country] => US [patent_app_date] => 2001-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4028 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/617/06617311.pdf [firstpage_image] =>[orig_patent_app_number] => 09719459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7015589 [patent_doc_number] => 20010051813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-13 [patent_title] => 'Systems, methods, and compositions for achieving closure of vascular puncture sites' [patent_app_type] => new [patent_app_number] => 09/780014 [patent_app_country] => US [patent_app_date] => 2001-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8532 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20010051813.pdf [firstpage_image] =>[orig_patent_app_number] => 09780014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5907943 [patent_doc_number] => 20020142950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'Methods for enhancing the bioavailability of a drug' [patent_app_type] => new [patent_app_number] => 09/781133 [patent_app_country] => US [patent_app_date] => 2001-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 21601 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20020142950.pdf [firstpage_image] =>[orig_patent_app_number] => 09781133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5802109 [patent_doc_number] => 20020010127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-24 [patent_title] => 'Controlled-release compositions containing opioid agonist and antagonist' [patent_app_type] => new [patent_app_number] => 09/781076 [patent_app_country] => US [patent_app_date] => 2001-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21715 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20020010127.pdf [firstpage_image] =>[orig_patent_app_number] => 09781076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6361171 [patent_doc_number] => 20020058618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'Method for the treatmennt or prevention of a disease mediated by the alpha-2B-adrenoceptor' [patent_app_type] => new [patent_app_number] => 09/773512 [patent_app_country] => US [patent_app_date] => 2001-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2448 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058618.pdf [firstpage_image] =>[orig_patent_app_number] => 09773512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1467200 [patent_doc_number] => 06458761 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-10-01 [patent_title] => 'Synthetic, statistic thymic peptide combination and its use as a preparation with immunological and/or endocrinological effect' [patent_app_type] => B2 [patent_app_number] => 09/766686 [patent_app_country] => US [patent_app_date] => 2001-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2720 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/458/06458761.pdf [firstpage_image] =>[orig_patent_app_number] => 09766686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7093715 [patent_doc_number] => 20010034320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-25 [patent_title] => 'NK1-receptor antagonists for treating restless legs syndrome' [patent_app_type] => new [patent_app_number] => 09/764629 [patent_app_country] => US [patent_app_date] => 2001-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2512 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20010034320.pdf [firstpage_image] =>[orig_patent_app_number] => 09764629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6638809 [patent_doc_number] => 20030211982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Beta turn peptidomimetic cyclic compounds' [patent_app_type] => new [patent_app_number] => 10/181546 [patent_app_country] => US [patent_app_date] => 2002-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10061 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211982.pdf [firstpage_image] =>[orig_patent_app_number] => 10181546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1315903 [patent_doc_number] => 06608027 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-19 [patent_title] => 'Macrocyclic peptides active against the hepatitis C virus' [patent_app_type] => B1 [patent_app_number] => 09/760946 [patent_app_country] => US [patent_app_date] => 2001-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36348 [patent_no_of_claims] => 145 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/608/06608027.pdf [firstpage_image] =>[orig_patent_app_number] => 09760946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6880586 [patent_doc_number] => 20010031873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-18 [patent_title] => 'Tetrapartate prodrugs' [patent_app_type] => new [patent_app_number] => 09/758993 [patent_app_country] => US [patent_app_date] => 2001-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15735 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20010031873.pdf [firstpage_image] =>[orig_patent_app_number] => 09758993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416440 [patent_doc_number] => 06511962 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-28 [patent_title] => 'Derivatives of laspartomycin and preparation and use thereof' [patent_app_type] => B1 [patent_app_number] => 09/760328 [patent_app_country] => US [patent_app_date] => 2001-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17384 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/511/06511962.pdf [firstpage_image] =>[orig_patent_app_number] => 09760328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1297881 [patent_doc_number] => 06623732 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-23 [patent_title] => 'Pharmaceutical formulation for nasal administration' [patent_app_type] => B1 [patent_app_number] => 09/674519 [patent_app_country] => US [patent_app_date] => 2001-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3344 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/623/06623732.pdf [firstpage_image] =>[orig_patent_app_number] => 09674519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6896384 [patent_doc_number] => 20010027174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-04 [patent_title] => 'Neo-tryptophan' [patent_app_type] => new [patent_app_number] => 09/755638 [patent_app_country] => US [patent_app_date] => 2001-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16368 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20010027174.pdf [firstpage_image] =>[orig_patent_app_number] => 09755638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1113101 [patent_doc_number] => 06803357 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-12 [patent_title] => 'Method of regulating glucose metabolism, and reagents related thereto' [patent_app_type] => B1 [patent_app_number] => 09/601432 [patent_app_country] => US [patent_app_date] => 2001-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 19067 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/803/06803357.pdf [firstpage_image] =>[orig_patent_app_number] => 09601432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6901661 [patent_doc_number] => 20010023244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-20 [patent_title] => 'New crystalline forms' [patent_app_type] => new [patent_app_number] => 09/753655 [patent_app_country] => US [patent_app_date] => 2001-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10237 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20010023244.pdf [firstpage_image] =>[orig_patent_app_number] => 09753655 [rel_patent_id] =>[rel_patent_doc_number] =>)